Synergistic interaction between trimetazidine and ketoprophen in mice

Synergistic interaction between trimetazidine and ketoprophen in mice

Recent studies have demonstrated the antinociceptive, anti-inflammatory, and gastric protective effects of trimetazidine (TDZ) on various models in rats. The present study proposes to demonstrate the antinociceptive action in mice, evaluated in conditions of inflammatory pain, together with the dete...

Full description

Bibliographic Details
Main Authors:	Daniela Carmen Ababei, Sorin Beşchea, Monica Neamţu, A. Vasincu, Oana Arcan, Veronica Bild
Format:	Article
Language:	English
Published:	Romanian National Association of the Veterinary Products Manufacturers 2015-06-01
Series:	Medicamentul Veterinar
Subjects:	antinociceptive effect ketoprofen abdominal constrictive response trimetazidine
Online Access:	http://www.veterinarypharmacon.com/docs/1534-2015_VD_ART_5.EN.pdf

Similar Items

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
by: Murathan Küçük, et al.
Published: (2020-01-01)

TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study
by: Naveen Seecheran, et al.
Published: (2019-07-01)

Protective Role of Trimetazidine Against Neomycin-induced Hair Cell Damage in Zebrafish
by: Jiwon Chang, et al.
Published: (2013-12-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

The synergistic combination of trimetazidine, hypoxen and L-carnitine in endurance sports
by: Hamid A Merchant
Published: (2022-12-01)

Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice
by: Yan Yang, et al.
Published: (2021-01-01)

Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity
by: A. A. Avagimyan, et al.
Published: (2023-11-01)

CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01)

Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
by: Alexandru Vasincu, et al.
Published: (2023-06-01)

The effect of oral and intraurethral trimetazidine use on urethral healing
by: Ali Ayyildiz, et al.
Published: (2016-09-01)

Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine
by: Suman Jatain, et al.
Published: (2016-11-01)

Efficacy of Trimetazidine in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Contrast Coronary Intervention: A Systematic Review and Meta-Analysis (PRISMA)
by: Tiny Nair, et al.
Published: (2024-04-01)

Trimetazidine Effect on Neutrophils count in Post IKKP
by: Taka Mehi, et al.
Published: (2016-05-01)

TRIMETAZIDINE ADDITION TO ANTIANGINAL THERAPY: EFFECTS ON EFFICACY AND QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA TREATED OUTPATIENTLY
by: M A Shalenkova
Published: (2012-04-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Biochemical Aspects That Lead to Abusive Use of Trimetazidine in Performance Athletes: A Mini-Review
by: Amalia Pușcaș, et al.
Published: (2024-01-01)

Central Beneficial Effects of Trimetazidine on Psychomotor Performance in Normal Healthy Volunteers
by: Hayder M Al-Kuraishy, et al.
Published: (2017-01-01)

Trimetazidine Prevents Oxidative Changes Induced in a Rat Model of Sporadic Type Of Alzheimer's Disease
by: Gholamreza Hassanzadeh, et al.
Published: (2015-01-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

Effects of trimetazidine and perindopril on myocardialfunction and metabolism in postmyocardial infarction patients with cardiac failure
by: A V Shabrov, et al.
Published: (2003-09-01)

The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict
by: Z. Yu. Shakhbiyeva, et al.
Published: (2019-03-01)

Evaluation of the efficiency of combined pharmacotherapy with the use of trimetazidine with prolonged release in patients with stable angina in outpatient practice
by: Yu V Luneva, et al.
Published: (2019-08-01)

Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial
by: Lili Wu, et al.
Published: (2020-06-01)

Clinical Efficacy of Trimetazidine and Holistic Management in the Treatment of Coronary Heart Disease
by: Li QU, et al.
Published: (2018-06-01)

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK
by: Hongyang Shu, et al.
Published: (2021-09-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Effect of trimetazidine on myocardial salvage index in patients with acute ST segment elevation myocardial infarction undergoing primary PCI
by: Foad Khaled, et al.
Published: (2013-09-01)

Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy – Six months follow-up result
by: A. Momen, et al.
Published: (2016-11-01)

INFLUENCE OF TRIMETAZIDINE METABOLIC THERAPY ON CONNECTIVE TISSUE METABOLISM IN EXPERIMENTAL DIFFUSE ISCHEMIC NECROTIC CARDIOSCLEROSIS IN RATS WITH DIFFERENT RATES OF HYPOXIA RESISTANCE
by: H. S. Saturska, et al.
Published: (2016-05-01)

MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE
by: M. Yu. Sitnikova, et al.
Published: (2015-11-01)

Therapeutic possibilities of myocardial cytoprotector trimetazidine MR incoronary heart disease
by: D. I Trukhan
Published: (2014-12-01)

Metabolic study of trimetazidine using ultra-high performance liquid chromatography-tandem mass spectrometry
by: Kamila Chomaničová, et al.
Published: (2023-05-01)

THE USAGE OF TRIMETAZIDINE AND SULODEXIL TO PREVENT TRANSFORMATION OF A NON-Q MI INTO A Q-MI
by: A. A. Abdullaev, et al.
Published: (2001-10-01)

Analgesic and anti-inflammatory activity of Artemisia extracts on animal models of nociception
by: IVANESCU Bianca, et al.
Published: (2021-03-01)

Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial
by: Zhong-Liang Dai, et al.
Published: (2021-10-01)

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION
by: S. V. Vasilyev, et al.
Published: (2014-12-01)

Trimetazidine with an adjuvant therapy to normalize the circulating visfatin concentration: Future perspective and mechanistic strategies
by: G. Uma Maheswari, et al.
Published: (2023-12-01)